Kenichi Ogiwara
12PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Dec 05, 2024
A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples.Naruto Shimonishi, Kenichi Ogiwara, Kengo Onishi
|Oct 30, 2024
Factor X consumption attenuates the coagulation effect of emicizumab: a case of severe hemophilia A treated with emicizumab and factor VIII-bypassing agents.Kuniyoshi Mizumachi, Kenichi Ogiwara, Yuto Nakajima
|Jan 16, 2024
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children.Takashi Nakagawa, Kenichi Ogiwara, Hitoshi Tonegawa
|Jul 19, 2023
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.Masahiro Takeyama, Naoki Matsumoto, Hiroto Abe
|Feb 13, 2023
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida
|Jul 21, 2022
Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B.Atsuko Nishiyama, Kenichi Ogiwara, Kuniyoshi Mizumachi
Pageof 2
